Suppr超能文献

D - 二聚体:癌症筛查、监测及预后评估问题的潜在解决方案

D-Dimer: A Potential Solution to Problems of Cancer Screening, Surveillance, and Prognosis Assessment.

作者信息

Siddiqui Nabeel A, Malik Mushrin, Wijeratne Fernando Ransirini, Sreekantan Nair Archana, Illango Janan, Gor Rajvi, Hamid Pousette

机构信息

Research, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Neurology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

出版信息

Cureus. 2021 May 16;13(5):e15064. doi: 10.7759/cureus.15064.

Abstract

Research has established a direct link between the plasma level of D-dimer and underlying malignancy. D-dimer has a strong association with the detection and prognosis of several cancers. For these reasons, this literature review aimed to evaluate the usefulness of elevated D-dimer levels in the initial screening of cancer, cancer recurrence surveillance, and for use as a cancer prognostic tool. A search of PubMed up to February 1, 2021, was carried out by reviewers. This literature review includes studies investigating the relationship between pretreatment plasma D-dimer levels and cancer. From the findings, pretreatment D-dimer levels can assist with cancer screening and prognosis assessment. Pretreatment plasma D-dimer levels can function as an effective cancer recurrence control. Elevated pre-treatment plasma D-dimer concentration is valuable in facilitating cancer screening, predicting an augmented risk of cancer recurrence, and anticipating a worse cancer prognosis.

摘要

研究已证实血浆D - 二聚体水平与潜在恶性肿瘤之间存在直接联系。D - 二聚体与多种癌症的检测及预后密切相关。基于这些原因,本综述旨在评估D - 二聚体水平升高在癌症初筛、癌症复发监测以及作为癌症预后工具方面的实用性。评审人员检索了截至2021年2月1日的PubMed数据库。本综述纳入了研究治疗前血浆D - 二聚体水平与癌症关系的研究。研究结果表明,治疗前D - 二聚体水平有助于癌症筛查和预后评估。治疗前血浆D - 二聚体水平可作为有效的癌症复发控制指标。治疗前血浆D - 二聚体浓度升高对于促进癌症筛查、预测癌症复发风险增加以及预示癌症预后较差具有重要价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc29/8205645/90a40f4cf49f/cureus-0013-00000015064-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验